Myriad Genetics (MYGN) Net Cash Flow Growth (5y) (2014 - 2026)
Myriad Genetics (MYGN) Net Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | Myriad Genetics | 414.15 Mn | 289.75 Mn | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.87% |
| Dec 31, 2025 | 40.38% |
| Sep 30, 2025 | 28.78% |
| Jun 30, 2025 | -17.29% |
| Mar 31, 2025 | -17.85% |
| Dec 31, 2024 | 15.55% |
| Sep 30, 2024 | 27.86% |
| Jun 30, 2024 | -16.77% |
| Mar 31, 2024 | -39.21% |
| Dec 31, 2023 | 83.90% |
| Sep 30, 2023 | -7.25% |
| Jun 30, 2023 | 26.04% |
| Mar 31, 2023 | -20.48% |
| Dec 31, 2022 | -84.82% |
| Sep 30, 2022 | 18.47% |
| Jun 30, 2022 | -21.45% |
| Mar 31, 2022 | -54.00% |
| Dec 31, 2021 | -28.05% |
| Sep 30, 2021 | 64.08% |
| Jun 30, 2021 | 10.40% |